RELATING TO PRIOR AUTHORIZATION OF HEALTH CARE SERVICES.
SB1449 addresses prior authorization practices for health care services in Hawaii. The bill finds that prior authorization can create administrative burden for physicians, contribute to burnout, and delay or disrupt patient care, while many denials are later overturned on appeal. To respond to those concerns, the bill requires utilization review entities doing business in the state to submit annual data on prior authorization activity to the State Health Planning and Development Agency.
The bill also creates a Health Care Appropriateness and Necessity Working Group within the agency. That group is tasked with identifying the most respected clinical standards, guidelines, and appropriate use criteria for common services that trigger prior authorization, assessing whether prior authorization is appropriate for those services, and recommending standards for reviewer expertise, decision time frames, and longer authorization periods for chronic or long-term treatments. The group must report its findings and any proposed legislation to the legislature each year beginning before the 2026 session.
In addition to reporting and review, the bill defines key terms such as prior authorization, prior authorization data, and utilization review entity. It also limits the submission of protected health information unless disclosure is authorized or otherwise permitted under federal privacy rules. The reporting agency must compile and publish findings by insurer, setting, and line of business, and it must notify the legislature if it misses the reporting deadline.
The bill’s impact on state law is to add a new data-reporting and policy-review framework to Chapter 323D of the Hawaii Revised Statutes, expanding oversight of insurers and other entities that conduct prior authorization. It does not directly ban prior authorization or make the working group’s recommendations mandatory, but it creates a formal process for transparency, benchmarking, and possible future reforms. The measure also encourages statewide agreement on standards and automation to reduce delays in medically necessary care.
The general sentiment reflected in the bill text and voting history is favorable toward reforming prior authorization. The findings emphasize patient harm, physician frustration, and inefficiency, and the bill passed Senate committees unanimously or near-unanimously. The main points of contention are likely to be the added reporting burden on insurers and utilization review entities, the scope of data collection, and whether the state should move from advisory recommendations to binding standards. However, the bill itself tries to balance those concerns by making the working group advisory only and by excluding protected health information except where permitted by law.
SB1449 amends Chapter 323D, Hawaii Revised Statutes, by adding new provisions requiring annual prior authorization data reporting by utilization review entities and establishing a Health Care Appropriateness and Necessity Working Group within the State Health Planning and Development Agency. It expands state oversight of health plan utilization review practices, requires public reporting of aggregated findings, and creates a continuing advisory process that may inform future legislation or administrative action. The bill affects insurers, health maintenance organizations, mutual benefit societies, fraternal benefit societies, other benefit administrators, health care providers, and consumers, while preserving federal privacy protections for protected health information.
The bill appears to have broad support in committee, with unanimous or near-unanimous passage in the Senate Health and Human Services and Senate Commerce and Consumer Protection committees. The findings section is strongly critical of prior authorization, framing the bill as a response to administrative burden, delayed care, and patient safety concerns. At the same time, the bill’s structure suggests a measured approach: it seeks transparency and recommendations rather than immediate mandates, which may have helped it advance with limited opposition in the available record.
The main areas of potential contention are between health plans/utilization review entities and providers/consumers. Insurers may view the annual reporting requirements and the working group’s scrutiny as an administrative burden and a step toward tighter regulation, while physicians and patient advocates are likely to support the bill because it aims to reduce delays and burnout. Another possible point of debate is the breadth of data requested, including patient demographics and request outcomes, although the bill limits disclosure of protected health information. Finally, because the working group’s recommendations are advisory only, some reform advocates may see the bill as too modest, while opponents may still object to it as an incremental move toward more state involvement in prior authorization standards.